Anbio Biotechnology

Anbio Biotechnology has launched two products: a Chikungunya IgM/IgG Rapid Test to address rising cases of the mosquito-borne illness, and the AP-100 Ultra-Fast PCR system. The AP-100 is a point-of-care diagnostic tool delivering results in 15 minutes. This 668g device features an extraction-free workflow and covers multiple pathogens like COVID-19 and Flu A/B. Anbio plans to expand its testing portfolio to include diagnostics for tuberculosis and HPV.